Drug recalls, alerts, and new therapies

This page is your source for pharmacy-related safety alerts, drug recalls, new therapies and generics, and other medication information.

Drug alerts

01/14/2014
Detrol LA® is available as a generic
We want to let you know Detrol LA® is now available as a generic. Detrol LA® treats patients with an overactive bladder.
Detrol LA® (96Kb)

01/02/2014
Cymbalta
We want to let you know Cymbalta® is now available as a generic.
Cymbalta (96Kb)

12/19/2013
FreeStyle Test Strips Recall
The manufacturer of FreeStyle and FreeStyle Lite Blood Glucose Test Strips is recalling these items because when used with the FreeStyle Blood Glucose Meter or the FreeStyle Flash Blood Glucose Meter they can show glucose readings that are lower than they really are.
FreeStyle and FreeStyle Lite Blood Glucose Test Strips Recalled (99.5Kb)

03/26/2013
Atorvastatin Drug Recall
The manufacturer of atorvastatin has issued a voluntary recall of certain lots of this medicine.
Atorvastatin recalled (25Kb)

03/26/2013
Pradaxa Drug Recall
The manufacturer of Pradaxa is recalling one lot of Pradaxa due to a potential packaging defect.
Pradaxa recalled (300Kb)

03/26/2013
Generic Suboxone Available
Suboxone is now available as a generic.
Suboxone is available as a generic (93Kb)

09/14/2012
Actos and ActoPlus Met are available as generics (pioglitazone and pioglitazone/metformin)
We want to let you know Actos and ActoPlus Met are now available as generics, pioglitazone and pioglitazone/metformin. Actos and the combination drug ActoPlus Met are used to treat patients with type 2 diabetes.
Actos and ActoPlus Met are available as generics (166Kb)

09/14/2012
Packages of Nimodipine Capsules, 30 mg Recalled
The manufacturer of Nimodipine is recalling certain packages of the medicine due to the discovery that some capsules may contain crystallized material.
Packages of Nimodipine Capsules, 30 mg Recalled (77Kb)

08/24/2012
Singulair is available as a generic (montelukast)
We want to let you know Singulair is now available as a generic. Singulair treats asthma and allergies.
Singulair is available as a generic (165Kb)

08/24/2012
Detrol is available as a generic (tolterodine)
We want to let you know Detrol is now available as a generic. Detrol treats patients with overactive bladder. Ask your doctor or pharmacist if the generic, tolterodine, is right for you.
Detrol is available as a generic (167Kb)

06/15/2012
Introvale (levonorgestrel and ethinyl estradiol) Packages Recalled
The manufacturer of Introvale is recalling certain packages of the medicine due to the discovery that the active pills (which are a peach color) and placebo pills (which are white) in some packs may be in the wrong order.
Introvale (levonorgestrel and ethinyl estradiol) Packages Recalled (98Kb)

6/8/2012
Gilenya (fingolimod) Can Cause Serious Side Effects, Including Slow Heart Rate
According to the U.S. Food and Drug Administration (FDA), using Gilenya (fingolimod) can cause serious side effects such as slow heart rate (bradycardia), which can lead to dizziness, fatigue, and heart palpitations. Gilenya is a medicine that is used to treat relapsing forms of multiple sclerosis, also known as MS.
Your Medicine May Cause Side Effects (150.61Kb)

06/01/2012
Plavix is Available as a Generic (Clopidogrel)
Plavix is now available as a generic called clopidogrel. Plavix is used to help prevent blood platelets from forming clots in people who have heart disease or poor circulation, usually in the legs (also called peripheral artery disease). Plavix is also prescribed to people who have had a recent heart attack or stroke.
Plavix is Available as a Generic (Clopidogrel) (166.5Kb)

05/25/2012
Certain Packages of Hydromorphone Injection Recalled
Certain packages of hydromorphone injection USP, 1 mg/mL, 1 mL fill in 2.5 mL Carpuject have been recalled by its manufacturer, Hospira Inc.
Packages of Hydromorphone Injection Recalled (77Kb)

05/04/2012
Certain packages of morphine sulfate injection USP, 4 mg/mL, 1 mL fill recalled
The manufacturer of morphine sulfate injection is recalling certain packages of the medicine due to a consumer report of two Carpuject syringes that had more than 1 mL of morphine sulfate.
Packages of Morphine Sulfate Injection Recalled (76Kb)

04/19/2012
FDA Revises Safety Labels for Statins
The U.S. Food and Drug Administration (FDA) revised the safety labels on statins, a class of medicines aimed at lowering cholesterol. The new information includes: mstrongory loss and confusion have been reported with statin use; increases in blood sugar levels have been reported with statin use; liver enzyme tests should be performed before starting statin therapy and as recommended by your doctor.
FDA Revises Safety Labels for Statins (150Kb)

04/19/2012
Aliskiren Products (Tekturna®, Tekturna HCT®, Takamlo®, Valturna® and Amturnide®) No Longer Recommended for Diabetic Patients also on an ACEI or ARB
The use of medicines that contain aliskiren with an ACEI or ARB can increase the risk of kidney problstrongs, low blood pressure, and increased potassium levels.
Aliskiren Products (Tekturna®, Tekturna HCT®, Takamlo®, Valturna® and Amturnide®) No Longer Recommended for Diabetic Patients also on an ACEI or ARB (27Kb)

03/05/2012
Packages of Norgestimate and Ethinyl Estradiol Recalled
The manufacturer of norgestimate and ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have tablets that are out of sequence.
Packages of Norgestimate and Ethinyl Estradiol Recalled (112Kb)

03/01/2012
Proton Pump Inhibitors (PPIs) May Increase Risk of Clostridium difficile-Associated Diarrhea (CDAD)
According to the U.S. Food and Drug Administration (FDA), using proton pump inhibitors (PPIs) may increase the risk of Clostridium difficile-associated diarrhea (CDAD).
Proton Pump Inhibitors (PPIs) May Increase Risk of Clostridium difficile-Associated Diarrhea (CDAD) (27Kb)

03/01/2012
FDA Issues Warning about Counterfeit Avastin®
According to the U.S. Food and Drug Administration (FDA), a counterfeit version of Avastin 400 mg/16 mL may have been bought and administered in 19 medical practices in the United States.
FDA Issues Warning about Counterfeit Avastin® (26Kb)

02/20/2012
Vials of Acetylcysteine Solution 20%, 30 mL Recalled
Lot Number 1877093 of acetylcysteine solution 20%, 30 mL vials has been recalled by its manufacturer due to the discovery of a visible glass particle in a vial within this lot.
Vials of Acetylcysteine Solution 20%, 30 mL Recalled (24Kb)

02/10/2012
Norvatis Consumer Health suspends production of Endo Pharmaceuticals products Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone.
The manufacturer of Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone® is suspending production due to a potential product mix-up in which tablets from one medicine may have been placed into packaging of another medicine.
Opana® ER, Opana®, Oxymorphone Hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, Morphine Sulfate Extended–Release, and Zydone® suspended from production (184Kb)

02/10/2012
Pfizer Inc. recalls packages of Lo/Ovral®-28 and norgestrel/ethinyl estradiol.
The manufacturer of Lo/Ovral®-28 and norgestrel/ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have the wrong number of active and inactive ingredient tablets and that the tablets may be out of sequence.
Packages of Lo/Ovral® and Norgestrel/Ethinyl Estradiol Recalled (110Kb)

11/17/2011
Zyprexa® is now available as a generic.
Zyprexa® is available as a generic (169Kb)

11/1/2011
According to the U.S. Food and Drug Administration (FDA), Avandia (a rosiglitazone-containing product), will no longer be dispensed through your local pharmacy effective Novstrongber 18, 2011.
Avandia® May Cause Side Effects (150Kb)

10/13/2011
According to the U.S. Food and Drug Administration (FDA), using repackaged Avastin® (bevacizumab) for eye injections can cause serious eye infections in rare cases.
Your Medicine May Cause Side Effects (32Kb)

10/13/2011
According to the FDA, using the antidepressant Celexa can lead to a rare ventricular tachycardia.
Your Medicine May Cause Side Effects (32Kb)

10/13/2011
According to the FDA, using Reclast can lead to severe kidney failure in rare cases.
Your Medicine May Cause Side Effects (32Kb)

8/19/2011
According to the U.S. Food and Drug Administration (FDA), using Zyvox (linezolid) and psychiatric medications affecting serotonin levels, can cause side effects.
Your Medicine May Cause Side Effects (26Kb)

8/11/2011
Arixtra® is now available as a generic
Arixtra® is available as a generic (165Kb)

8/11/2011
Tamiflu® May Cause Side Effects
Tamiflu® May Cause Side Effects (166Kb)

8/11/2011
Valproate Medications May Cause Side Effects
Valproate Medications May Cause Side Effects (152Kb)

7/28/2011
Possible side effects of using Erythropoiesis-Stimulating Agents
According to the FDA, using Erythropoiesis-Stimulating Agents such as Procrit®, Epogen®, or Aranesp® for the treatment of anstrongia in patients with chronic kidney disease can cause an increased risk of harmful side effects.
Your Medicine May Cause Side Effects (148Kb)

7/15/2011
Recall of some butalbital, acetaminophen and caffeine tablets
The manufacturer of butalbital, acetaminophen and caffeine tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
Butalbital, Acetaminophen and Caffeine Tablets Recalled (23Kb)

7/15/2011
Recall of some Endocet® 10/325 mg tablets
The manufacturer of Endocet® 10/325 mg tablets is recalling some bottles of this medicine because some bottles may contain different strength tablets.
Endocet® 10/325 mg Tablets Recalled (26Kb)

7/15/2011
Recall of some hydrocodone and acetaminophen tablets
The manufacturer of hydrocodone and acetaminophen tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
Hydrocodone and Acetaminophen Tablets recalled (23Kb)

7/15/2011
The FDA says Simvastatin (Zocor) 80mg may cause muscle injury.
Your Medicine May Cause Side Effects (105Kb)

6/24/2011
Ropinirole 1 mg tablets recalled
One lot of Ropinirole 1 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
Ropinirole 1 mg tablets recalled (23Kb)

6/24/2011
Glyburide 2.5 mg tablets recalled
One lot of Glyburide 2.5 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
Glyburide 2.5 mg tablets recalled (23Kb)

5/20/2011
Allegra® and Allegra-D® are now available without a prescription
Allegra® (fexofenadine) and Allegra-D® (fexofenadine/pseudoephedrine) are now available over-the-counter (OTC) and may be purchased without a prescription.
Allegra® (fexofenadine) Available Over-The-Counter (39Kb)

5/20/2011
Important Recall Notice Regarding using tumor necrosis factor (TNF) blockers
According to the U.S. Food and Drug Administration (FDA), using tumor necrosis factor (TNF) blockers (medicines like Humira®, Enbrel®, Simponi®, Cimzia®, Rstrongicade®) , azathioprine, and/or mercaptopurine can cause side effects.
Your Medicine May Cause Side Effects (32Kb)

5/20/2011
Important Recall Notice Regarding Coumadin
One lot number of Coumadin 5 mg tablets has been recalled by its manufacturer, Bristol-Myers Squibb because a single tablet was found to be higher in potency than expected.
Coumadin® (warfarin sodium) 5 mg Tablets Recalled (28Kb)

4/28/2011
PPI extended usage causes unwanted side effects
According to the U.S. Food and Drug Administration (FDA), using Proton Pump Inhibitors (Nexium, Prevacid, Prilosec, etc) for an extended period of time may cause low magnesium levels.
Your Medicine May Cause Side Effects (32Kb)

4/28/2011
Xalatan now is available in generic form-latanoprost.
Xalatan®, a drug approved to help with the treatment of glaucoma, is now available as a generic, latanoprost.
Xalatan® is Available as a Generic (57Kb)

4/15/2011
Auralgan Otic Solution Rstrongoved From The Market
The FDA notified companies that make, ship, or sell Auralgan Otic Solution to stop. This is because the medicine does not have FDA approval and its labeling does not include adequate directions. This means Auralgan Otic Solution will no longer be available.
Auralgan Otic Solution Removed From The Market (57Kb)

01/01/11
Hydrocodone, Acetaminophen, and Phenobarbital Rstrongoved from Market
Qualitest Pharmaceuticals issued a voluntary nationwide recall of hydrocodone and acetaminophen tablets 10mg / 500mg and phenobarbital tablets 32.4 mg. An individual bottle of hydrocodone and acetaminophen tablets, 10mg / 500mg, 60 count was found incorrectly labeled with a phenobarbital tablets 32.4mg, 1000 count label.
Hydrocodone and Acetaminophen 10mg / 500mg Tablets and Phenobarbital 32.4mg Tablets Voluntarily Recalled (69Kb)

12/30/10
Generic Colchicine Rstrongoved From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
Generic Colchicine Removed From Market (30Kb)

12/30/10
Propoxyphene Rstrongoved From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
Propoxyphene Removed From Market (29Kb)

11/04/2010
Fentanyl Transdermal Patches Recalled by Actavis
Actavis is voluntarily recalling 18 lots of Fentanyl transdermal syststrong 25 mcg/h.
Important Recall Notice Regarding Fentanyl 25 mcg/h (35Kb)

10/16/2010
Important Recall Notice Regarding Methotrexate Injection
Sandoz Inc. is voluntarily recalling all 50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate Injection. Please read the attached for more information about this recall and further instructions.
mportant Recall Notice Regarding Methotrexate Injection (50Kb)

10/1/2010
A generic is now availble for StratteraTM
A generic is now available for Strattera. If you currently take Strattera and choose the generic alternative, your cost may be lower. Ask your doctor or pharmacist whether Atomoxetine (generic name of brand name Strattera) would be right for you.

9/28/2010
U.S. FDA issues a warning regarding possible link between the use of ARBs and a small increased risk of cancer.
On July 15, the U.S. Food and Drug Administration (FDA) issued a warning regarding a possible link between the use of angiotensin receptor blockers (ARBs) and a small increased risk of cancer based upon a recently published meta-analysis in Lancet Oncology. ARBs have been widely used since the approval of Cozaar® (losartan) in 1995. Currently seven ARBs are available, including Atacand® (candesartan), Avapro® (irbesartan), Benicar® (olmesartan), Cozaar (losartan), Diovan® (valsartan), Micardis® (telmisartan), and Teveten® (eprosartan).If you are currently taking a ARB, the FDA believes that ARB use is of significant benefit in disease states such as hypertension and heart failure, and recommends that ARBs continue to be used as recommended per approved manufacturer labels. To date, the FDA has not concluded that ARBs increase the risk of cancer.

7/1/2010
Pfizer Inc. has announced the voluntary withdrawal from the U.S. market of the drug Mylotarg
Mylotarg® (gemtuzumab ozogamicin) removed by its manufacturer Pfizer Inc. (30Kb)

3/18/2010
LifeScan is voluntarily recalling Test Strips
LifeScan is voluntarily recalling eight lots of OneTouch® SureStep® Test Strips.
Important Recall Notice Regarding OneTouch® SureStep® Test Strips (31Kb)

3/4/2010
OneTouch SureStep Test Strips recalled
8 lots of OneTouch SureStep Test Strips have been recalled by their manufacturer LifeScan
OneTouch® SureStep® Test Strips recalled by its manufacturer LifeScan (31Kb)

3/2/2010
Azmacort Inhalation Aerosol discontinued
Azmacort® (triamcinolone acetonide) Inhalation Aerosol discontinued
Azmacort® (triamcinolone acetonide) Inhalation Aerosol discontinued (36Kb)

2/23/2010
GlucoPro Insulin Syringes
Nipro Medical Corporation is voluntarily recalling all lots of GlucoPro® insulin syringes.
Important Recall Notice Regarding GlucoPro® Insulin Syringes (41Kb)

2/2/2010
GlucoPro®Insulin Syringes Recalled
GlucoPro Insulin Syringes Recalled by its manufacturer Nipro Medical Corporation
GlucoPro® Insulin Syringes Recalled by its manufacturer Nipro Medical Corporation (45Kb)

12/29/2009
Sanofi Pasteur H1N1 Pediatric Vaccine in Pre-Filled Syringes Recalled
Sanofi Pasteur has issued a non-safety related voluntarily recall of certain lots of H1N1 Pediatric (0.25 ml, for 6-35 months old) vaccine in pre-filled syringes.
Sanofi Pasteur H1N1 Pediatric Vaccine in Pre-Filled Syringes Recalled (36Kb)

11/3/2009
Accusure Insulin Syringes Recalled
Qualitest Pharmaceuticals, Inc. is voluntarily recalling all lots of Accusure Insulin Syringes.
Accusure Insulin Syringes Recalled by its manufacturer Qualitest Pharmaceuticals (27Kb)

9/2/2009
Accusure Insulin Syringes Recall
Specific lots of Accusure®Insulin Syringes have been recalled by its manufacturer Qualitest Pharmaceuticals, Inc.
Accusure® Insulin Syringes recalled by its manufacturer Qualitest Pharmaceuticals, Inc. (27Kb)

8/20/2009
Dextroamphetamine/Amphetamine 20mg Tablets Recall
Dextroamphetamine/Amphetamine 20mg tablets have been recalled by its manufacturer Barr Laboratories
Dextroamphetamine/Amphetamine 20mg tablets recalled by its manufacturer Barr Laboratories (27Kb)

8/11/2009
Casodex is Now Generic
On 7/1/09 Casodex became available in generic form
Casodex Is Now Generic (27Kb)

8/4/2009
BD Luer Lok Syringes
BD Luer Lok Syringes have been recalled by its manufacturer Becton-Dickenson
BD Luer Lok Syringes Recalled by its manufacturer Becton-Dickenson

7/30/2009
Quick-set Infusion Sets
Specific lots of Quick-Set Infusion Sets have been recalled by its manufacturer, Medtronic, Inc.
Quick-Set® Infusion Sets Recalled by its manufacturer Medtronic, Inc (34Kb)

5/12/2009
Topamax is Now Generic
On 4/1/09 TOPAMAX became available in generic form
Topamax Is Now Generic (300Kb)

4/7/2009
Digoxin 0.125 mg and 0.25 mg Tablets
Caraco Pharmaceutical Laboratories, Ltd., voluntarily recalls all lots of Digoxin tablets due to size variability
Digoxin Tablets by Caraco Pharmaceutical Laboratories, Ltd. Recalled (300Kb)

3/26/2009
Propafenone 225 mg Tablets
Watson Laboratories voluntarily recalls one lot due to the potential presence of oversized tablets
Propafenone 225 mg tablets (300Kb)

12/23/2008
CFC-Propelled Albuterol Inhalers
CFC-Propelled Albuterol Inhalers will not be Available Starting January 1, 2009
CFC-Propelled Albuterol Inhalers will not be Available Starting January 1, 2009 (300Kb)

12/23/2008
Multiple Medications by ETHEX Corp. Recalled
Six medications have been recalled due to the potential presence of oversized tablets
Multiple Medications by ETHEX Corp. Recalled (300Kb)

12/4/2008
ReliOn Insulin Syringes - Medical Device Recall
Mislabeled syringes may lead to an overdose of as much as 2.5 times the intended dose
ReliOn Insulin Syringes-Medical Device Recall (300Kb)

10/15/2008
Dextroamphetamine Sulfate 5 mg Tablets
ETHEX Corp. voluntarily recalls three lots due to the potential presence of oversized tablets
Dextroamphetamine Sulfate 5 mg tablets (300Kb)

Learn benefits of different yoga styles and find which suits you best for life balance and strength

Try yoga for more life balance

Check out the different styles of yoga and find the one that fits you best.

Read about yoga’s benefits
How to stick to an exercise plan and be motivated to stay on track by not skipping work outs

Stay motivated to stay active

Tempted to skip your workouts? Get tips to help you stay on track.

Read about sticking to an exercise plan

Look up healthcare and health plan terms

From abrasion to X-ray, the Humana glossary offers explanations for common insurance and medical terms.

Browse our healthcare glossary